Effect of anti-epileptic drugs on serum level of igG subclasses

Iranian Journal of Pediatrics

Volumn 20, Issue 3, 2010, Pages 269-276

  Ashrafi, Mahmoud Reza ^a,b   Hosseini, Seyed Ahmad ^a,b   Biglari, Mohammad ^a   Abolmaali, Sarah ^a   Malamiri, Reza Azizi ^b,c   Mombeini, Hoda ^a   Pourpak, Zahra ^d   Saladjegheh, Narges ^e   Rezaei, Nima ^a,b   Saghafi, Shiva ^d   Aghamohammadi, Asghar ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Clinical Laboratory Maryam Hospital   (Iran)

Author keywords

Antiepileptic drugs; Epilepsy; Igg subclasses; Immunoglobulin g

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; PHENOBARBITAL; VALPROIC ACID;

ABSENCE; ADOLESCENT; ARTICLE; ATONIC SEIZURE; CHILD; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED SEIZURE; MONOTHERAPY; NEPHELOMETRY;

EID: 77957594404     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Holmes GL. New drugs in the treatment of epilepsy. Annales Nestle. 2003;61:107-117.
2. Berg AT, Shinnar S. The contributions of epidemiology to the understanding of childhood seizures and epilepsy. J Child Neurol. 1994;9 (suppl 2):19-26.
3. Berg AT. The epidemiology of seizures and epilepsy in children, In Shinnar S, Amir N, Branski D (eds). Childhood Seizures. Basel, Switzerland, S. Karger. 1995; p: 1-10.
4. Camfield CS, Camfield PR, Gordon K, et al. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996; 37(1):19-23.
5. Bardana EJ Jr, Gabourel JD, Davies GH, et al. Effects of phenytoin on man's immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody. Am J Med. 1983;74(2):289-296.
6. Gilhus NE, Strandjord RE, Aarli JA. The effect of carbamazepine on serum immunoglobulin concentrations. Acta Neurol Scand. 1982;66(2): 172-179.
7. Ranua J, Luoma K, Auvinen A, et al. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study. Epilepsy Behav. 2005; 6(2):191-195.
8. Aarli JA. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy. Acta Neurol Scand. 1976;54(5):423-430.
9. Lenti C, Masserini C, Peruzzi C, et al. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital J Neurol Sci. 1991;12(1): 87-91.
10. Go T. Carbamazepineinduced IgG1 and IgG2 deficiency associated with B cell maturation defect. Seizure. 2004;13(3):187-190.
11. Callenbach PM, Jol-Van Der Zijde CM, Geerts AT, et al. Dutch Study of Epilepsy in Childhood. Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood. Clin Exp Immunol. 2003; 132(1):144-151.
12. Maeoka Y, Hara T, Dejima S, Takeshita K. IgA and IgG2 deficiency associated with zonisamide therapy: a case report. Epilepsia. 1997;38(5): 611-613.
13. Castro AP, Redmershi MG, Pastorino AC, et al. Secondary hypogammaglobulinemia after use of carbamazepine: case report and review. Rev Hosp Clin Fac Med Sao Paulo. 2001;56(6):189-192.
14. Kato Z, Watanabe M, Kondo N. IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment. Eur J Pediatr. 2003; 162(3):209-211.
15. Gilhus NE, Lea T. Carbamazepine: effect on IgG subclasses in epileptic patients. Epilepsia. 1988; 29(3):317-320.
16. Gilhus NE, Strandjord RE, Aarli JA. Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital. Eur Neurol. 1982;21(4):284-288.
17. Winckler MI, Rotta NT. Clinical and electroencephalographic follow-up after a first unprovoked seizure. Pediatr Neurol. 2004; 30(3): 201-206.
18. Wilson SB, Scheuer ML, Emerson RG, et al. Seizure detection: evaluation of the Reveal algorithm. Clin Neurophysiol. 2004;115(10): 2280-2291.
19. Commission on classification and terminology of the international league against epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30(4): 389-399.
20. Schur PH, Rosen F, Norman ME. Immunoglobulin subclasses in normal children. Pediatr Res. 1979;13(3):181-183.
21. Stiehm ER, Fudenberg HH. Serum levels of immune globulins in health and disease: a survey. Pediatrics. 1966; 37(5):715-727.
22. Palace J, Lang B. Epilepsy: an autoimmune disease? J Neurol Neurosurg Psychiatry. 2000; 69(6):711-714.
23. Aarli JA. Epilepsy and the immune system. Arch Neurol. 2000;57(12):1689-1692.
24. Najjar S, Bernbaum M, Lai G, Devinsky O. Immunology and epilepsy. Rev Neurol Dis. 2008; 5(3):109-116.
25. Aghamohammadi A, Lougaris L, Plebani A, et al. Predominantly antibody deficiencies. In: Rezaei N, Aghamohammadi A, Notarangelo LD (eds). Primary immunodeficiency diseases: definition, diagnosis and management. Berlin Heidelberg; Springer. 2008; Pp: 97-130.
26. Başaran N, Hincal F, Kansu E, et al. Humoral and cellular immune parameters in untreated and phenytoinor carbamazepinetreated epileptic patients. Int J Immunopharmacol. 1994;16(12): 1071-1077.
27. Aarli JA, Tönder O. Effect of antiepileptic drugs on serum and salivary IgA. Scand J Immunol. 1975;4(4):391-396.
28. Sorrell TC, Forbes IJ. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol. 1975;20(2):273-285.
29. Fossan GO. Effect of phenytoin on the immune response in rabbits. Int Arch Allergy Appl Immunol. 1977; 54: 338-346.
30. Bardana EJ Jr, Gabourel JD, Davies GH, Craig S. Effects of phenytoin on man's immunity: evaluation of changes in serum immunoglobulins, complement and antinuclear antibody. Am J Med. 1983;74(2):289-296.
31. Aarli JA, Tönder O. Immunological aspects of neurological diseases. Monogr Neural Sci. 1980; 6: 1-184.
32. Cereghino JJ. Immunological aspects of epilepsy and antiepileptic drugs. In: Oxley J, Janz D, Meinardi H (eds). Antiepileptic therapy: chronic toxicity of antiepileptic drugs. New York; Raven Press, 1983; Pp: 251-29.
33. Pacifici R, Paris L, Di Carlo S, et al. Immunologic aspects of carbamazepine treatment in epileptic patients. Epilepsia. 1991;32(1):122-127.
34. Siber GR, Schur PH, Aisenberg AC, et al. Correlation between serum IgG-2 concen-trations and the antibody response to bacterial polysaccharide antigens. N Engl J Med. 1980; 303(4):178-182.
35. Schur PH. IgG subclasses--a review. Ann Allergy. 1987;58(2):89-96.
36. Plebani A, Duse M, Monafo V. Recurrent infections with IgG2 deficiency. Arch Dis Child. 1985;60(7):670-672.